Search Results 341-350 of 20230 for Off-label
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Overview.
Entacapone is used in combination with levodopa/carbidopa to treat end-of-dose "wearing off" effect in patients with Parkinson's disease, sometimes called ...
... label extension study (OLE) Day 1. Use of these agents is prohibited during the study. - Treatment with oral or sublingual immunotherapy within 6 months of ...
For non-prescription products, read the label or package ingredients carefully. ... Throw away any unused portions of the mixture. Do ... Keep out of the ...
For non-prescription products, read the label or package ingredients carefully. ... Tell your doctor right away ... unconsciousness. Some side effects may occur ...
For non-prescription products, read the label or package ingredients carefully. ... Tuberculosis, active or history of—This medicine can reduce the body's ability ...
Clinical Trials · A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with ...
This will help prevent serious breathing problems and severe sleepiness that can lead to death. Call for emergency help right away after the first dose of this ...
Check with your doctor right away if you have cough, difficulty swallowing, dizziness, fast heartbeat, rash, itching, trouble breathing, or unusual tiredness or ...
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection. Print ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.